SCHEMBL4792514

SCHEMBL4792514

CC(CO)NC(=O)Oc1[nH]c2ccc(N(Cc3ccccc3)S(=O)(=O)c3ccc(C(C)(C)C)cc3)cc2c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 5/20 0.41
PTGES O14684 3/20 0.38
ALOX5 P09917 2/20 0.38
KEAP1 Q14145 2/20 0.38
NFE2L2 Q16236 2/20 0.38
NR3C1 P04150 2/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 2/20 0.36
CA9 Q16790 2/20 0.36
TRPM8 Q7Z2W7 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
RORC P51449 1/20 0.36
OXTR P30559 1/20 0.36
AVPR1A P37288 1/20 0.36
PTPN22 Q9Y2R2 2/20 0.36
BCL2L1 Q07817 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4762525 0.89 CA1 (0.36) KEAP1NFE2L2NR3C1CA12CA1
SCHEMBL4762138 0.88 MCL1 (0.45) MCL1PTGESALOX5KEAP1NFE2L2
SCHEMBL5156271 0.87 CA1 (0.43) MCL1PTGESALOX5KEAP1NFE2L2
SCHEMBL4659730 0.83 MCL1 (0.37) MCL1PTGESALOX5NR3C1TRPM8
SCHEMBL3944734 0.82 BRD4 (0.50) NR3C1CA1CA2
SCHEMBL4760593 0.82 BRD4 (0.44) CA12CA1CA2CA4CA9
SCHEMBL4762136 0.80 MCL1 (0.49) MCL1PTGESALOX5KEAP1NFE2L2
SCHEMBL5155038 0.79 CA1 (0.42) KEAP1NFE2L2CA12CA1CA2
SCHEMBL5152108 0.78 CA1 (0.43) MCL1PTGESALOX5KEAP1NFE2L2
SCHEMBL4659506 0.77 PTGDR2 (0.37) KEAP1NFE2L2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001847-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS Bayer Schering Pharma AG (DE) 2008-12-17 EP claimed
WO-2007107385-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-09-27 WO claimed
EP-2001847-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS Bayer Schering Pharma AG (DE) 2008-12-17 EP disclosed
WO-2007107385-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-09-27 WO disclosed